Applying Tyrvaya® (Varenicline Solution) Savings Offer for Eligible Patients

News
Video

Sponsored Content

Sponsored Content: Step-by-step instructions for pharmacy staff to enroll eligible patients in the Tyrvaya Savings Offer to reduce out-of-pocket costs.

Indication
Tyrvaya® (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.

Important Safety Information
The most common adverse reaction reported is 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation.

Please click here for full Prescribing Information.

Pharmacist: Let’s get started and learn about the comprehensive savings program available to your patients prescribed Tyrvaya® (varenicline solution) and how to ensure eligible patients are enrolled in the Tyrvaya® Savings Offer.

With the Tyrvaya® savings offer, patients with commercial insurance may pay as little as $10 for a 30-day or 90-day prescription.

Patients waiting to see if their commercial insurance covers Tyrvaya can get up to one 30-day fill for $10 while their coverage is being processed.

*Limitations apply. Eligible, commercially insured patients with coverage for Tyrvaya® pay as little as $10, up to a savings maximum of $275 for each 30-day prescription, and as little as $10, up to a savings maximum of $825 for each 90-day prescription. Patient is responsible for any out-of-pocket costs once monthly savings limit is reached. Eligible, commercially insured patients awaiting a coverage decision from their insurance plan pay $10 for one 30-day prescription, for up to 1 fill. This Savings Offer expires December 31st, 2024. Offer not valid under Medicare, Medicaid, or any other federal or state program. Offer not valid for non-insured/ cash-paying patients. Oyster Point reserves the right to change or discontinue this offer at any time, without notice. See complete Terms and Conditions at Tyrvaya.com for details. See complete Terms & Conditions for details after this video.

Help patients with commercial insurance save on their Tyrvaya® by providing them information on how to enroll in the savings offer when they come to pick up their prescription at the pharmacy.

  • Patients will need to get the savings offer online at TyrvayaSavings.com. Direct them to fill out the form to get the savings offer.
  • If they’re eligible, the savings offer will be ready to use immediately.
  • Patients will need to keep their savings offer number handy—advise them to either take a screenshot or save it to their phone.

Here are step by step instructions on how to apply the Savings Offer when running the patient’s claim:

  • For commercially insured patients, please submit this claim to the patient’s primary insurance. This offer will cover one OCC 3 claim (limited to a 30-day supply while waiting on coverage determination) and one OCC 8 claim. Please initiate the Prior Authorization for OCC 3 claims.

You can direct patients to these resources to reinforce appropriate administration and resources for administration at home. These are available at tyrvaya.com and the savings offer can be found at tyrvayasavings.com.

Download the “how to guide” to read instructions for using Tyrvaya® and watch the “How to use Tyrvaya®” demonstration video – both available at tyrvaya.com/how-to-use

Review the full Instructions for Use with your patients before they use Tyrvaya®. Remind patients to consult the Instructions for Use that comes with their prescription before administering.

For individuals who ask about management options for dry eye signs and symptoms, direct them to speak with their eye doctor for more information and to see if Tyrvaya® is right for them.

For more information, including Prescribing Information and Instructions for Use, please visit tyrvaya-pro.com.

Continue watching this video series to learn how to apply this information in a consultation session between a pharmacist and patient picking up their newly prescribed Tyrvaya® from the community pharmacy.

TYR-2023-0012 06/24

© 2024 MJH Life Sciences

All rights reserved.